Transmedics Group Inc (TMDX)

R&D Expense Growth

27.14%

Quarterly · Period ending:

TMDX logo

TMDX R&D Expense Growth

Latest reported27.14%
TMDX Quarterly R&D Growth (QoQ) (0.00% → 27.14%)
High-resolution chart · PNG

TMDX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Transmedics Group Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
27.1434%
20.1826%
35.6553%
-4.2299%
-7.1445%
4.2274%
15.4073%
2.9441%
21.775%
5.7523%
-71.9356%
362.4774%
41.2196%
1.9979%
-15.4524%
1.4001%
-10.884%
19.3221%
22.2932%
-17.9825%
38.9011%
-0.3518%
9.4585%
6.4566%
-37.3012%
-0.5909%
26.7868%
3.1753%
23.3127%
11.3597%
6.5403%
-4.6898%
-0.9235%
1.8519%
0%
-18.8648%
2.8578%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.